Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Novavax Inc (NVAX)    
$8.58 0.07 (0.81%) as of 4:30 Fri 4/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 208,509,000 as of 12/25
Market Cap: 1.79(B)
Last Volume: 2,409,350 Avg Vol: 2,820,427
52 Week Range: $3.82 - $9.71
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    : 10.7
Insider 6 Months    : 10.7
Insider 3/6 Months : 20.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Novavax is a clinical-stage biopharmaceutical company focused on developing recombinant vaccines to address a range of infectious diseases. Co.'s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant protein micelle vaccines. Co.'s product pipeline targets a range of infectious diseases and its vaccine candidates are in or have completed clinical trials that target seasonal influenza, pandemic influenza, and respiratory syncytial virus. Further, CPL Biologics Private Limited, Co.'s joint venture company in India, is developing a rabies vaccine candidate.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 46,235 46,235 136,197 489,351
Total Buy Value $114,340 $114,340 $399,133 $1,307,867
Total People Bought 7 7 7 9
Total Buy Transactions 7 7 19 35
Total Shares Sold 0 2,076,701 2,093,510 8,137,510
Total Sell Value $0 $10,451,198 $10,521,127 $40,443,828
Total People Sold 0 2 3 6
Total Sell Transactions 0 5 6 15
End Date 2015-01-25 2014-10-24 2014-04-25 2013-04-25

   
Records found: 160
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Glenn Gregory M SVP, Research and Development   •       –      –    2015-03-12 4 GD $0.00 $0 D/D 600 266     -
   Mcmanus Michael A Jr Director   –       •      –    2015-02-20 4 OE $1.48 $96,600 D/D 45,000 122,590     -
   Hahn Timothy Jon SVP, Manufacturing   •       –      –    2015-01-31 4 B $2.28 $21,270 D/D 9,329 110,485 2.74 12%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2015-01-31 4 B $2.28 $1,974 D/D 866 866 2.66 12%     
   Wilson Russell P SVP, Business Development   •       –      –    2015-01-31 4 B $2.28 $11,514 D/D 5,050 64,939 2.74 12%     
   Erck Stanley C CEO and President   •       •      –    2015-01-31 4 B $2.28 $13,958 D/D 6,122 97,778 2.81 12%     
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2015-01-31 4 B $2.28 $19,125 D/D 8,388 37,044 2.74 12%     
   Trizzino John SVP, Commercial Operations   •       –      –    2015-01-31 4 B $3.63 $23,998 D/D 6,611 28,611 2.74 12%     
   Herrmann John A Iii SVP, General Counsel   •       –      –    2015-01-31 4 B $2.28 $22,501 D/D 9,869 26,483 2.74 12%     
   Evans Gray C Director   –       •      –    2014-12-16 4 OE $1.03 $264,250 D/D 250,000 360,680     -
   Evans Gray C Director   –       •      –    2014-12-16 4 S $5.72 $266,915 D/D (46,701) 313,979 -54%     
   Evans Gray C Director   –       •      –    2014-12-12 4 S $5.77 $172,962 D/D (30,000) 110,680 -54%     
   Modi Rajiv I. Director   –       •      –    2014-11-20 4 S $5.02 $2,604,823 I/I (518,889) 7,500,000     -
   Modi Rajiv I. Director   –       •      –    2014-11-18 4 S $5.01 $472,668 I/I (94,345) 8,018,889 -73%     
   Modi Rajiv I. Director   –       •      –    2014-11-17 4 S $5.00 $6,933,830 I/I (1,386,766) 8,113,234 -77%     
   Hahn Timothy Jon SVP, Manufacturing   •       –      –    2014-10-03 4 B $4.05 $10,125 D/D 2,500 101,156 2.74 95%     
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-10-03 4 B $4.11 $20,550 D/D 5,000 28,656 2.74 95%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-09-26 4 S $4.16 $69,929 D/D (16,809) 0 -91%     
   Hahn Timothy Jon SVP, Manufacturing   •       –      –    2014-09-25 4 B $4.17 $37,530 D/D 9,000 98,656 2.74 88%     
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-07-31 4 B $2.28 $28,972 D/D 12,707 16,809 2.74 81%     
   Erck Stanley C CEO and President   •       •      –    2014-07-31 4 B $2.28 $15,477 D/D 6,788 91,656 2.81 81%     
   Wilson Russell P SVP, Business Development   •       –      –    2014-07-31 4 B $2.28 $11,375 D/D 4,989 59,889 2.74 81%     
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-07-31 4 B $2.28 $20,037 D/D 8,788 23,656 2.74 81%     
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2014-07-31 4 B $2.28 $21,067 D/D 9,240 89,656 2.74 81%     
   Herrmann John A Iii SVP, General Counsel   •       –      –    2014-07-31 4 B $2.28 $20,406 D/D 8,950 16,614 2.74 81%     

  160 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed